• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[应用Hpa II-PCR技术对慢性髓性白血病降钙素基因甲基化的研究]

[Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].

作者信息

Tan B, Cao P, Qi Z

机构信息

Department of Hematology, Xiangya Hospital, Hunan Medical University, Changsha 410008.

出版信息

Hunan Yi Ke Da Xue Xue Bao. 1999;24(4):371-3.

PMID:12080652
Abstract

To investigate the role of calcitonin(CT) gene hypermethylation in the transformation from the initial chronic phase to blast crisis of chronic myeloid leukemia, 31 CML patients were studied by using Hpa II-PCR. The results showed that the 10.52%(2/19) chronic phase, 71.4%(5/7) accelerated phase and 80.0%(4/5) blast crisis of patients had CT gene hypermethylation and that the increased methylation of the CT gene were related with the disease progression. The reports indicated that the hypermethylation of CT gene might be a useful marker for predicting the evolution of CML and selecting chronic phase patients for BMT.

摘要

为探讨降钙素(CT)基因高甲基化在慢性髓性白血病从慢性期向急变期转化中的作用,采用Hpa II-PCR方法对31例慢性髓性白血病患者进行研究。结果显示,慢性期患者CT基因高甲基化率为10.52%(2/19),加速期为71.4%(5/7),急变期为80.0%(4/5),CT基因甲基化程度增加与疾病进展相关。报告指出,CT基因高甲基化可能是预测慢性髓性白血病病情演变及选择慢性期患者进行骨髓移植的有用标志物。

相似文献

1
[Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].[应用Hpa II-PCR技术对慢性髓性白血病降钙素基因甲基化的研究]
Hunan Yi Ke Da Xue Xue Bao. 1999;24(4):371-3.
2
[Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia].
Ai Zheng. 2003 Jun;22(6):616-9.
3
[Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].[慢性髓性白血病急变期与p16及降钙素基因异常的关系]
Zhonghua Zhong Liu Za Zhi. 2000 Mar;22(2):151-3.
4
[The methylation of CT gene in chronic myeloid leukemia].[慢性髓性白血病中CT基因的甲基化]
Zhonghua Nei Ke Za Zhi. 1997 Jun;36(6):394-7.
5
[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].STI571治疗慢性髓性白血病患者的临床疗效及副作用
Ai Zheng. 2004 Apr;23(4):421-5.
6
Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.慢性髓性白血病患者中BCL-X(L)表达及STAT5磷酸化的差异
Eur J Haematol. 2004 Apr;72(4):231-8. doi: 10.1046/j.0902-4441.2003.00201.x.
7
Hypermethylation of the calcitonin gene and leukemia.降钙素基因的高甲基化与白血病
Nouv Rev Fr Hematol (1978). 1991;33(6):551-3.
8
[Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].[通过实时定量逆转录聚合酶链反应检测和定量慢性髓性白血病患者的BCR-ABL转录本]
Zhonghua Yi Xue Za Zhi. 2005 Feb 23;85(7):453-7.
9
Expression of programmed cell death proteins in patients with chronic myeloid leukemia.慢性髓性白血病患者中程序性细胞死亡蛋白的表达
J BUON. 2008 Jul-Sep;13(3):403-8.
10
Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.慢性髓性白血病中死亡相关蛋白激酶1(DAPK1)CpG岛的异常甲基化。
Eur J Haematol. 2009 Feb;82(2):119-23. doi: 10.1111/j.1600-0609.2008.01178.x. Epub 2008 Nov 6.